Silencing speckle-type POZ protein by promoter hypermethylation decreases cell apoptosis through upregulating Hedgehog signaling pathway in colorectal cancer
Authors:
Open Access
- 29 December 2016
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 7 (12) , e2569
Abstract
Epigenetic silencing of tumor suppressors contributes to the development and progression of colorectal cancer (CRC). We recently found that speckle-type POZ protein (SPOP) was significantly downregulated and the inactivation of SPOP promoted metastasis in CRC. This study aimed to clarify its epigenetic alteration, molecular mechanisms and clinical significance in CRC. Our results revealed that the core region of SPOP promoter was hypermethylated in CRC tissues and its methylation was correlated with poor survival. Transcription factor RXRA had a vital role in the regulation of SPOP gene. The data indicated that DNA methylation at −167 bp of the SPOP gene altered the binding affinity between transcription factor RXRA and SPOP promoter. Moreover, SPOP was found to associate with Gli2 and promoted its ubiquitination and degradation in CRC. Consequently, the expression level of Hh/Gli2 pathway-related apoptotic protein Bcl-2 was decreased and the function of resisting cell death was inhibited in CRC. It suggests that methylation status of SPOP promoter can be used as a novel epigenetic biomarker and a therapeutic target in CRC.Keywords
This publication has 30 references indexed in Scilit:
- Epigenetics and colorectal cancerNature Reviews Gastroenterology & Hepatology, 2011
- Interactions between Hedgehog proteins and their binding partners come into viewGenes & Development, 2010
- Structures of SPOP-Substrate Complexes: Insights into Molecular Architectures of BTB-Cul3 Ubiquitin LigasesMolecular Cell, 2009
- Molecular Classification and Correlates in Colorectal CancerThe Journal of Molecular Diagnostics, 2008
- Repression of IFN Regulatory Factor 8 by DNA Methylation Is a Molecular Determinant of Apoptotic Resistance and Metastatic Phenotype in Metastatic Tumor CellsCancer Research, 2007
- The Epigenomics of CancerCell, 2007
- Ubiquitin ligases: cell-cycle control and cancerNature Reviews Cancer, 2006
- Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasisOncogene, 2006
- Epigenetic Inactivation of ID4 in Colorectal Carcinomas Correlates with Poor Differentiation and Unfavorable PrognosisClinical Cancer Research, 2004
- Effects of DNA methylation on DNA-binding proteins and gene expressionCurrent Opinion in Genetics & Development, 1993